Clinical Characterization of Respiratory Syncytial Virus Infection in Adults: A Neglected Disease?

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2023 Sep 28

PMID 37766255

Authors

Cassia F Estofolete

Cecilia A Banho

Alice T Verro

Flora A Gandolfi

Barbara F Dos Santos

Livia Sacchetto

Beatriz de C Marques

Nikos Vasilakis

Mauricio L Nogueira

Affiliations

Soon will be listed here.

Abstract

Lower respiratory tract infections (LRIs) are a significant cause of disability-adjusted life-years (DALYs) across all age groups, especially in children under 9 years of age, and adults over 75. The main causative agents are viruses, such as influenza and respiratory syncytial virus (RSV). Viral LRIs in adults have historically received less attention. This study investigated the incidence of RSV and influenza in adult patients admitted to a referral hospital, as well as the clinical profile of these infections. Molecular testing was conducted on nasopharyngeal samples taken from a respiratory surveillance cohort comprising adult (15-59 years) and elderly (60+ years) hospitalized patients who tested negative for SARS-CoV-2, to determine the prevalence for influenza and RSV. Influenza was found to be less frequent among the elderly. The main symptoms of RSV infections were cough, fever, dyspnea, malaise, and respiratory distress, while headache, nasal congestion, a sore throat, and myalgia were most frequent in influenza. Elderly patients with RSV were not found to have more severe illness than adults under age 60, underscoring the importance of providing the same care to adults with this viral infection.

Citing Articles

Observational Study on the Clinical Reality of Community-Acquired Respiratory Virus Infections in Adults and Older Individuals.

Nagasawa M, Udagawa T, Kato T, Tanaka I, Yamamoto R, Sakaguchi H Pathogens. 2024; 13(11).

PMID: 39599536 PMC: 11597395. DOI: 10.3390/pathogens13110983.

Calabro G, Rizzo C, Domnich A, de Waure C, Rumi F, Bonanni P J Prev Med Hyg. 2024; 65(2 Suppl 1):E1-E159.

PMID: 39554593 PMC: 11567645. DOI: 10.15167/2421-4248/jpmh2024.65.2s1.

Severe respiratory syncytial virus disease.

Pena-Lopez Y, Sabater-Riera J, Raj P J Intensive Med. 2024; 4(4):405-416.

PMID: 39310066 PMC: 11411437. DOI: 10.1016/j.jointm.2024.03.001.

Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel.

Michelin L, Bellei N, Ferreira da Costa Gomes M, Raboni S, Kairalla M, Correa R Hum Vaccin Immunother. 2024; 20(1):2388943.

PMID: 39161095 PMC: 11340750. DOI: 10.1080/21645515.2024.2388943.

Reservoirs of Nosocomial Pathogens in Intensive Care Units: A Systematic Review.

Osman A, Darkwah S, Kotey F, Odoom A, Hotor P, Dayie N Environ Health Insights. 2024; 18():11786302241243239.

PMID: 38828046 PMC: 11141231. DOI: 10.1177/11786302241243239.

References

DENNY Jr F . The clinical impact of human respiratory virus infections. Am J Respir Crit Care Med. 1995; 152(4 Pt 2):S4-12. DOI: 10.1164/ajrccm/152.4_Pt_2.S4. View

Choi Y, Hill-Ricciuti A, Branche A, Sieling W, Saiman L, Walsh E . Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017-2019. Influenza Other Respir Viruses. 2021; 16(1):151-158. PMC: 8692803. DOI: 10.1111/irv.12912. View

Bowser D, Rowlands K, Hariharan D, Gervasio R, Buckley L, Halasa-Rappel Y . Cost of Respiratory Syncytial Virus Infections in US Infants: Systematic Literature Review and Analysis. J Infect Dis. 2022; 226(Suppl 2):S225-S235. PMC: 9377037. DOI: 10.1093/infdis/jiac172. View

Uyeki T, Hui D, Zambon M, Wentworth D, Monto A . Influenza. Lancet. 2022; 400(10353):693-706. PMC: 9411419. DOI: 10.1016/S0140-6736(22)00982-5. View

Nair H, Brooks W, Katz M, Roca A, Berkley J, Madhi S . Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet. 2011; 378(9807):1917-30. DOI: 10.1016/S0140-6736(11)61051-9. View

. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Respir Med. 2021; 9(9):1030-1049. PMC: 8410610. DOI: 10.1016/S2213-2600(21)00164-8. View

Chuaychoo B, Ngamwongwan S, Kaewnaphan B, Athipanyasilp N, Horthongkham N, Kantakamalakul W . Clinical manifestations and outcomes of respiratory syncytial virus infection in adult hospitalized patients. J Clin Virol. 2019; 117:103-108. PMC: 7106545. DOI: 10.1016/j.jcv.2019.07.001. View

Pavia A . Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin Infect Dis. 2011; 52 Suppl 4:S284-9. PMC: 3106235. DOI: 10.1093/cid/cir043. View

Domachowske J, Halczyn J, Bonville C . Preventing Pediatric Respiratory Syncytial Virus Infection. Pediatr Ann. 2018; 47(9):e371-e376. DOI: 10.3928/19382359-20180816-01. View

10.

Falsey A, Hennessey P, Formica M, Cox C, Walsh E . Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005; 352(17):1749-59. DOI: 10.1056/NEJMoa043951. View

11.

Nott R, Fuller T, Brasil P, Nielsen-Saines K . Out-of-Season Influenza during a COVID-19 Void in the State of Rio de Janeiro, Brazil: Temperature Matters. Vaccines (Basel). 2022; 10(5). PMC: 9143486. DOI: 10.3390/vaccines10050821. View

12.

Alonso W, Viboud C, Simonsen L, Hirano E, Daufenbach L, Miller M . Seasonality of influenza in Brazil: a traveling wave from the Amazon to the subtropics. Am J Epidemiol. 2007; 165(12):1434-42. DOI: 10.1093/aje/kwm012. View

13.

Javanian M, Barary M, Ghebrehewet S, Koppolu V, Vasigala V, Ebrahimpour S . A brief review of influenza virus infection. J Med Virol. 2021; 93(8):4638-4646. DOI: 10.1002/jmv.26990. View

14.

Cilloniz C, Luna C, Hurtado J, Marcos M, Torres A . Respiratory viruses: their importance and lessons learned from COVID-19. Eur Respir Rev. 2022; 31(166). PMC: 9724808. DOI: 10.1183/16000617.0051-2022. View

15.

Eden J, Sikazwe C, Xie R, Deng Y, Sullivan S, Michie A . Off-season RSV epidemics in Australia after easing of COVID-19 restrictions. Nat Commun. 2022; 13(1):2884. PMC: 9130497. DOI: 10.1038/s41467-022-30485-3. View

16.

Mosegui G, Antonanzas Villar F, Vianna C . Burden of disease attributed to acute respiratory infections in South America. J Infect Dev Ctries. 2022; 16(10):1614-1622. DOI: 10.3855/jidc.17009. View

17.

Shi T, McAllister D, OBrien K, Simoes E, Madhi S, Gessner B . Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017; 390(10098):946-958. PMC: 5592248. DOI: 10.1016/S0140-6736(17)30938-8. View

18.

Simoes E . Overlap between respiratory syncytial virus infection and influenza. Lancet. 2001; 358(9291):1382-3. DOI: 10.1016/S0140-6736(01)06488-1. View

19.

Ackerson B, An J, Sy L, Solano Z, Slezak J, Tseng H . Cost of Hospitalization Associated With Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults. J Infect Dis. 2020; 222(6):962-966. DOI: 10.1093/infdis/jiaa183. View